Patent foramen ovale and migraine, a fortuitus association or a causal relationship?;Foramen ovale perméable et migraines: Association fortuite ou relation causale?

Revue Medicale de Liege

Volumn 61, Issue 5-6, 2006, Pages 362-368

  Schoenen, Jean ^a,b   Burette, Ph ^a   Materne, P ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Centre Hospitalier Regional de La Citadelle   (Belgium)

Author keywords

Migraine; Patent foramen ovale; Stroke

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DECOMPRESSION SICKNESS; DISEASE ASSOCIATION; DIVER; HEART ATRIUM SEPTUM DEFECT; HEREDITY; HUMAN; MIGRAINE; MIGRAINE AURA; PREVALENCE; RISK FACTOR; SPREADING CORTICAL DEPRESSION;

ADULT; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MIGRAINE DISORDERS;

EID: 33745903405     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Hagen PT, Scholz DG, Edwards WD.- Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc, 1984, 59, 17-20.
2. Diener HC, Weimar C, Katsarava Z.- Patent foramen ovale: paradoxical connection to migraine and stroke. Curr Opin Neurol, 2005, 18, 299-304
3. Wilmshurst P, Nightingale S.- Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci, 2001, 100, 215-220.
4. International Headache Society.- The International Classification of Headache Disorders: 2nd edition.( ICHD-II) Cephalalgia, 2004, 24, 9-160.
5. Jauss M, Zanette E.- Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis, 2000, 10, 490-496.
6. Heckmann JG, Niedermeier W, Brandt-Pohlmann M, et al.- Detection of patent foramen ovale. Transesophageal echocardiography and transcranial Doppler sonography with ultrasound contrast media are "supplementary, not competing, diagnostic methods". Med Klin, 1999, 94, 367-370.
7. Wammers-van der Heijden EA, Tijssen CC, Egberts ACG.- Right-to-left shunt and migraine: the strength of the relationship. Cephalalgia, 2006, 26, 208-213.
8. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G.- Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology, 1999, 52, 1622-1625.
9. Schwerzmann M, Nedeltchev K, Lagger F, et al.- Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology, 2005, 65, 1415-1418.
10. Del Sette M, Angeli S, Leandri M, et al.- Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis, 1998, 8, 327-330.
11. Lamy C, Giannesini C, Zuber M, et al.- Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Stroke, 2002, 33, 706-711.
12. Etminan M, Takkouche B, Isorna FC, Samii A.- Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ, 2004, 20, 20.
13. Kruit MC, van Buchem MA, Hofman PA, et al.- Migraine as a risk factor for subclinical brain lesions. JAMA, 2004, 291, 427-434.
14. Swartz RH, Kern RZ.- Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol, 2004, 61, 1366-1368
15. Sándor P., Ambrosini A., Agosti R.M., Schoenen J.- Genetics of migraine: possible links to neurophysiological abnormalities. Headache, 2002, 42, 365-377.
16. Schoenen J., Sandor P. S.- Headache with focal neurological signs or symptoms: a complicated differential diagnosis. Lancet Neurology, 2004, 3, 237-245.
17. Fumal A., Schoenen J.- La génétique des Migraines: des canaux ioniques aux polymorphismes de nucléotide unique. Rev Med Liège, 2004, 59, 367-377.
18. Sándor P.S., U. Dydak, J. Schoenen, et al.- MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura patients. Cephalalgia, 2005, 25, 507-518.
19. Schoenen J, Jamart B, Delwaide P.J.- Cartographic é lectroencéphalographique dans les migraines en périodes critique et intercritique. Rev EEG Neurophysiol Clin, 1987, 17, 289-299.
20. Woods RP, Iacoboni M, Mazziotta JC: Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. New Eng J Med, 1994, 331, 1689-1692.
21. Schoenen J.A. Ambrosini, P.S. Sandor, A. Maertens de Noordhout.- Evoked potentials and transcranial magnetic stimulation in migraine published data and viewpoint on their pathophysiologic significance. Clinical Neurophysiology, 2003, 114, 955-972.
22. Schoenen J.- Shunt cardiaque droite-gauche: étiologie possible de migraine avec aura? Migraine Contact, 2002, 2, 19-20.
23. Wilmshurst P T, M J Pearson, S Nightingale, et al.- Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart, 2004, 90, 1315-1320.
24. Mas JL, Arquizan C, Lamy C, et al.- Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001, 345, 1740-1746.
25. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL.- Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet, 2000, 356, 1648-1651.
26. Morandi E, Anzola GP, Angeli S, et al.- Transcatheter closure of patent foramen ovale: a new migraine treatment? J Interv Cardiol, 2003, 16, 39-42.
27. Schwerzmann M, Wiher S, Nedeltchev K, et al.- Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology, 2004, 62, 1399-1401.
28. Post M, Thijs V, Herroelen L, Budts W.- Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology, 2004, 62, 1439-1440.
29. Mortelmans K, Post M, Thijs V, et al.- The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J, 2005, 26, 1533-1537.
30. Migraine-Nimodipine European Study Group M. European multicenter trial of nimodipine in the prophylaxis of classic migraine (migraine with aura). Headache, 1989, 29, 639-642.
31. Stewart WF, Shetcher A, Rasmussen BK.- Migraine prevalence - a review of population-based studies. Neurology, 1994, 44, 817-823.
32. O'Neill BP, Mann JD.- Aspirin prophylaxis in migraine. Lancet, 1978, 2, 1179-1181.
33. Baldrati A, Cortelli P, Procaccianti G, et al.- Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study. Acta Neurol Scand, 1983, 67, 181-186.
34. Buring JE, Peto R, Hennekens CH.- Low-dose aspirin for migraine prophylaxis. JAMA, 1990, 264, 1711-1713.
35. Grotemeyer KH, Scharafinski HW, Schlake HP, Husstedt IW.- Acetylsalicylic acid vs. metoprolol in migraine prophylaxis: a double-blind cross-over study. Headache, 1990, 10, 639-641.
36. Diener HC, Hartung E, Chrubasik J, et al.- A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia, 2001, 21, 120-128.
37. Sharifi M, Burks J.- Efficacy of clopidogrel in the treatment of post-ASD closure migraines. Catheter Cardiovasc Interv, 2004, 63, 255.
38. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL.- Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart, 2005, 91, 1173-1175.
39. Sztajzel R, Genoud D, Roth S, et al.- Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis, 2002, 13, 102-106.
40. Van Puijenbroek EP, Egberts JF, Trooster JFG, Zomerdijk J.- Reduction of migrainous headaches during the use of acenocoumarol. Headache, 1996, 36, 48.
41. Meissner I, Whisnant JP, Khandheria BK, et al.- Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc, 1999, 74, 862-869.
42. Domitrz I, Mieszkowski J, Kwiecinski H.- The prevalence of patent foramen ovale in patients with migraine. Neural Neurochir Pol, 2004, 38, 89-92.